How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing
As COVID-19 has reached pandemic status and the number of cases continues to grow, widespread availability of diagnostic testing is critical in helping identify and control the emergence of this rapidly spreading and serious illness. However, a lacking in making a quick reaction to the threat and st...
Gespeichert in:
Veröffentlicht in: | Talanta (Oxford) 2021-01, Vol.222, p.121534-121534, Article 121534 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 121534 |
---|---|
container_issue | |
container_start_page | 121534 |
container_title | Talanta (Oxford) |
container_volume | 222 |
creator | Moulahoum, Hichem Ghorbanizamani, Faezeh Zihnioglu, Figen Turhan, Kutsal Timur, Suna |
description | As COVID-19 has reached pandemic status and the number of cases continues to grow, widespread availability of diagnostic testing is critical in helping identify and control the emergence of this rapidly spreading and serious illness. However, a lacking in making a quick reaction to the threat and starting early development of diagnostic sensing tools has had an important impact globally. In this regard, here we will review critically the current developed diagnostic tools in response to the COVID-19 pandemic and compare the different types through the discussion of their pros and cons such as nucleic acid detection tests (including PCR and CRISPR), antibody and protein-based diagnosis tests. In addition, potential technologies that are under development such as on-site diagnosis platforms, lateral flow, and portable PCR units are discussed. Data collection and epidemiological analysis could also be an interesting factor to incorporate with the emerging technologies especially with the wide access to smartphones. Lastly, a SWOT analysis and perspectives on how the development of novel sensory platforms should be treated by the different decision-makers are analyzed.
[Display omitted]
•COVID 19 has become a major issue for society recently.•Developing performant diagnostic tools is crucial.•Many technologies have the potential to answer the needs for quick diagnostics.•On-site tools and smartphones needs more focus to stop viral spread.•A collaboration between law and decision makers is needed for better disease control. |
doi_str_mv | 10.1016/j.talanta.2020.121534 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7423517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039914020308250</els_id><sourcerecordid>2459352488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-9f429eb1b987b895cf21ee87d47459be45bb690d1d0fb5ecc8a664a395105f0f3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EokPhEUBessng3yTeUKEptJUqlQWwtRz7ZuqZxE7jZNC8Bk-M2xlGsGJl6fqcc38-hN5SsqSElh82y8l0JkxmyQjLNUYlF8_QgtYVL7is-HO0IISrQlFBztCrlDaEEMYJf4nOOKdlxQRboF_X8SdO93HuHHberENMk7d466eEHeygi0MPYcLGmWHCD7O3226PfcCrux83l5iqovNbwIMJDvps7KODLl3gr2NMOBexjSHh2OIEIcVxj4fOTG0c-4TnBO6UVFD1JPFh_Rq9aE2X4M3xPUffv3z-troubu-ublafbgsrymoqVCuYgoY2qq6aWknbMgpQV05UQqoGhGyaUhFHHWkbCdbWpiyF4UpSIlvS8nP08ZA7zE0PzuY1R9PpYfS9Gfc6Gq___Qn-Xq_jTleCcUmrHPD-GDDGhxnSpHufLHQZC8Q5aZbn4JKJus5SeZDafJc0QntqQ4l-5Kk3-shTP_LUB57Z9-7vGU-uPwCz4OIgyFeHnYdRJ-shWHB-BDtpF_1_WvwGICO2MA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2459352488</pqid></control><display><type>article</type><title>How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Moulahoum, Hichem ; Ghorbanizamani, Faezeh ; Zihnioglu, Figen ; Turhan, Kutsal ; Timur, Suna</creator><creatorcontrib>Moulahoum, Hichem ; Ghorbanizamani, Faezeh ; Zihnioglu, Figen ; Turhan, Kutsal ; Timur, Suna</creatorcontrib><description>As COVID-19 has reached pandemic status and the number of cases continues to grow, widespread availability of diagnostic testing is critical in helping identify and control the emergence of this rapidly spreading and serious illness. However, a lacking in making a quick reaction to the threat and starting early development of diagnostic sensing tools has had an important impact globally. In this regard, here we will review critically the current developed diagnostic tools in response to the COVID-19 pandemic and compare the different types through the discussion of their pros and cons such as nucleic acid detection tests (including PCR and CRISPR), antibody and protein-based diagnosis tests. In addition, potential technologies that are under development such as on-site diagnosis platforms, lateral flow, and portable PCR units are discussed. Data collection and epidemiological analysis could also be an interesting factor to incorporate with the emerging technologies especially with the wide access to smartphones. Lastly, a SWOT analysis and perspectives on how the development of novel sensory platforms should be treated by the different decision-makers are analyzed.
[Display omitted]
•COVID 19 has become a major issue for society recently.•Developing performant diagnostic tools is crucial.•Many technologies have the potential to answer the needs for quick diagnostics.•On-site tools and smartphones needs more focus to stop viral spread.•A collaboration between law and decision makers is needed for better disease control.</description><identifier>ISSN: 0039-9140</identifier><identifier>ISSN: 1873-3573</identifier><identifier>EISSN: 1873-3573</identifier><identifier>DOI: 10.1016/j.talanta.2020.121534</identifier><identifier>PMID: 33167242</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Clinical Laboratory Techniques - instrumentation ; Clinical Laboratory Techniques - methods ; Coronavirus Infections - diagnosis ; Coronavirus Infections - epidemiology ; COVID-19 ; COVID-19 Testing ; Diagnostic kits ; Humans ; Pandemics ; Pneumonia, Viral - diagnosis ; Pneumonia, Viral - epidemiology ; Point-of-Care Testing ; Reagent Kits, Diagnostic ; Response strategies ; Review ; SARS-CoV-2 ; Sensors/biosensors</subject><ispartof>Talanta (Oxford), 2021-01, Vol.222, p.121534-121534, Article 121534</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><rights>2020 Elsevier B.V. All rights reserved. 2020 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-9f429eb1b987b895cf21ee87d47459be45bb690d1d0fb5ecc8a664a395105f0f3</citedby><cites>FETCH-LOGICAL-c467t-9f429eb1b987b895cf21ee87d47459be45bb690d1d0fb5ecc8a664a395105f0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0039914020308250$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33167242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moulahoum, Hichem</creatorcontrib><creatorcontrib>Ghorbanizamani, Faezeh</creatorcontrib><creatorcontrib>Zihnioglu, Figen</creatorcontrib><creatorcontrib>Turhan, Kutsal</creatorcontrib><creatorcontrib>Timur, Suna</creatorcontrib><title>How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing</title><title>Talanta (Oxford)</title><addtitle>Talanta</addtitle><description>As COVID-19 has reached pandemic status and the number of cases continues to grow, widespread availability of diagnostic testing is critical in helping identify and control the emergence of this rapidly spreading and serious illness. However, a lacking in making a quick reaction to the threat and starting early development of diagnostic sensing tools has had an important impact globally. In this regard, here we will review critically the current developed diagnostic tools in response to the COVID-19 pandemic and compare the different types through the discussion of their pros and cons such as nucleic acid detection tests (including PCR and CRISPR), antibody and protein-based diagnosis tests. In addition, potential technologies that are under development such as on-site diagnosis platforms, lateral flow, and portable PCR units are discussed. Data collection and epidemiological analysis could also be an interesting factor to incorporate with the emerging technologies especially with the wide access to smartphones. Lastly, a SWOT analysis and perspectives on how the development of novel sensory platforms should be treated by the different decision-makers are analyzed.
[Display omitted]
•COVID 19 has become a major issue for society recently.•Developing performant diagnostic tools is crucial.•Many technologies have the potential to answer the needs for quick diagnostics.•On-site tools and smartphones needs more focus to stop viral spread.•A collaboration between law and decision makers is needed for better disease control.</description><subject>Clinical Laboratory Techniques - instrumentation</subject><subject>Clinical Laboratory Techniques - methods</subject><subject>Coronavirus Infections - diagnosis</subject><subject>Coronavirus Infections - epidemiology</subject><subject>COVID-19</subject><subject>COVID-19 Testing</subject><subject>Diagnostic kits</subject><subject>Humans</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - diagnosis</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Point-of-Care Testing</subject><subject>Reagent Kits, Diagnostic</subject><subject>Response strategies</subject><subject>Review</subject><subject>SARS-CoV-2</subject><subject>Sensors/biosensors</subject><issn>0039-9140</issn><issn>1873-3573</issn><issn>1873-3573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhS0EokPhEUBessng3yTeUKEptJUqlQWwtRz7ZuqZxE7jZNC8Bk-M2xlGsGJl6fqcc38-hN5SsqSElh82y8l0JkxmyQjLNUYlF8_QgtYVL7is-HO0IISrQlFBztCrlDaEEMYJf4nOOKdlxQRboF_X8SdO93HuHHberENMk7d466eEHeygi0MPYcLGmWHCD7O3226PfcCrux83l5iqovNbwIMJDvps7KODLl3gr2NMOBexjSHh2OIEIcVxj4fOTG0c-4TnBO6UVFD1JPFh_Rq9aE2X4M3xPUffv3z-troubu-ublafbgsrymoqVCuYgoY2qq6aWknbMgpQV05UQqoGhGyaUhFHHWkbCdbWpiyF4UpSIlvS8nP08ZA7zE0PzuY1R9PpYfS9Gfc6Gq___Qn-Xq_jTleCcUmrHPD-GDDGhxnSpHufLHQZC8Q5aZbn4JKJus5SeZDafJc0QntqQ4l-5Kk3-shTP_LUB57Z9-7vGU-uPwCz4OIgyFeHnYdRJ-shWHB-BDtpF_1_WvwGICO2MA</recordid><startdate>20210115</startdate><enddate>20210115</enddate><creator>Moulahoum, Hichem</creator><creator>Ghorbanizamani, Faezeh</creator><creator>Zihnioglu, Figen</creator><creator>Turhan, Kutsal</creator><creator>Timur, Suna</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210115</creationdate><title>How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing</title><author>Moulahoum, Hichem ; Ghorbanizamani, Faezeh ; Zihnioglu, Figen ; Turhan, Kutsal ; Timur, Suna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-9f429eb1b987b895cf21ee87d47459be45bb690d1d0fb5ecc8a664a395105f0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Clinical Laboratory Techniques - instrumentation</topic><topic>Clinical Laboratory Techniques - methods</topic><topic>Coronavirus Infections - diagnosis</topic><topic>Coronavirus Infections - epidemiology</topic><topic>COVID-19</topic><topic>COVID-19 Testing</topic><topic>Diagnostic kits</topic><topic>Humans</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - diagnosis</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Point-of-Care Testing</topic><topic>Reagent Kits, Diagnostic</topic><topic>Response strategies</topic><topic>Review</topic><topic>SARS-CoV-2</topic><topic>Sensors/biosensors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moulahoum, Hichem</creatorcontrib><creatorcontrib>Ghorbanizamani, Faezeh</creatorcontrib><creatorcontrib>Zihnioglu, Figen</creatorcontrib><creatorcontrib>Turhan, Kutsal</creatorcontrib><creatorcontrib>Timur, Suna</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Talanta (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moulahoum, Hichem</au><au>Ghorbanizamani, Faezeh</au><au>Zihnioglu, Figen</au><au>Turhan, Kutsal</au><au>Timur, Suna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing</atitle><jtitle>Talanta (Oxford)</jtitle><addtitle>Talanta</addtitle><date>2021-01-15</date><risdate>2021</risdate><volume>222</volume><spage>121534</spage><epage>121534</epage><pages>121534-121534</pages><artnum>121534</artnum><issn>0039-9140</issn><issn>1873-3573</issn><eissn>1873-3573</eissn><abstract>As COVID-19 has reached pandemic status and the number of cases continues to grow, widespread availability of diagnostic testing is critical in helping identify and control the emergence of this rapidly spreading and serious illness. However, a lacking in making a quick reaction to the threat and starting early development of diagnostic sensing tools has had an important impact globally. In this regard, here we will review critically the current developed diagnostic tools in response to the COVID-19 pandemic and compare the different types through the discussion of their pros and cons such as nucleic acid detection tests (including PCR and CRISPR), antibody and protein-based diagnosis tests. In addition, potential technologies that are under development such as on-site diagnosis platforms, lateral flow, and portable PCR units are discussed. Data collection and epidemiological analysis could also be an interesting factor to incorporate with the emerging technologies especially with the wide access to smartphones. Lastly, a SWOT analysis and perspectives on how the development of novel sensory platforms should be treated by the different decision-makers are analyzed.
[Display omitted]
•COVID 19 has become a major issue for society recently.•Developing performant diagnostic tools is crucial.•Many technologies have the potential to answer the needs for quick diagnostics.•On-site tools and smartphones needs more focus to stop viral spread.•A collaboration between law and decision makers is needed for better disease control.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33167242</pmid><doi>10.1016/j.talanta.2020.121534</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0039-9140 |
ispartof | Talanta (Oxford), 2021-01, Vol.222, p.121534-121534, Article 121534 |
issn | 0039-9140 1873-3573 1873-3573 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7423517 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Clinical Laboratory Techniques - instrumentation Clinical Laboratory Techniques - methods Coronavirus Infections - diagnosis Coronavirus Infections - epidemiology COVID-19 COVID-19 Testing Diagnostic kits Humans Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - epidemiology Point-of-Care Testing Reagent Kits, Diagnostic Response strategies Review SARS-CoV-2 Sensors/biosensors |
title | How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T00%3A29%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=How%20should%20diagnostic%20kits%20development%20adapt%20quickly%20in%20COVID%2019-like%20pandemic%20models?%20Pros%20and%20cons%20of%20sensory%20platforms%20used%20in%20COVID-19%20sensing&rft.jtitle=Talanta%20(Oxford)&rft.au=Moulahoum,%20Hichem&rft.date=2021-01-15&rft.volume=222&rft.spage=121534&rft.epage=121534&rft.pages=121534-121534&rft.artnum=121534&rft.issn=0039-9140&rft.eissn=1873-3573&rft_id=info:doi/10.1016/j.talanta.2020.121534&rft_dat=%3Cproquest_pubme%3E2459352488%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2459352488&rft_id=info:pmid/33167242&rft_els_id=S0039914020308250&rfr_iscdi=true |